MECP2 duplication syndrome
Log in to starLast updated Nov 4, 2026
A 4-year-old boy has severe intellectual disability, infantile hypotonia that has evolved into progressive spasticity, no expressive language, and a history of multiple hospitalizations for recurrent pneumonia. His mother and maternal aunt are healthy. Chromosomal microarray shows a duplication at Xq28 spanning MECP2.
X-linked; Xq28 duplication (0.3 to 4 Mb in affected males) that includes MECP2 (methyl-CpG-binding protein 2); gain of dosage, the opposite of the loss that causes Rett syndrome. The duplication often includes neighboring genes (IRAK1, L1CAM, and others, depending on its size).
- Almost exclusively affects males, with complete penetrance. Carrier females are typically asymptomatic because of highly skewed X-inactivation that silences the duplicated X.
- Carrier mothers account for most cases (inherited duplication); a minority are de novo. Each pregnancy of a carrier mother has a 50% chance of inheriting the duplication: sons who inherit it are affected, and daughters who inherit it are usually unaffected carriers.
- A subset of carrier women report anxiety, depression, and autistic features; counsel accordingly.
MeCP2 is a chromatin-bound nuclear protein that binds methylated DNA and regulates gene expression. It is best known as a transcriptional repressor but also takes part in RNA processing and active transcription, and it may regulate hundreds of genes in a cell-specific way. It is most abundant in neurons, where its level rises through postnatal development.
The duplication raises MeCP2 protein expression. Loss of MECP2 and gain of MECP2 both cause intellectual disability, so the brain needs a correct dose; neurons grown from patient stem cells carrying the duplication have abnormal shape and electrical behavior.
- Copy number matters most: a triplication gives a more severe phenotype than a duplication. Large, cytogenetically visible duplications add growth deficiency, microcephaly, and urogenital anomalies.
- Affected females: most carry the extra copy on an autosome (an unbalanced X-autosome translocation or an insertion), so it escapes the skewing that protects most carriers.
- Testing: a copy number change needs microarray or genome copy number calling; a G-banded karyotype detects only duplications over about 8 Mb.
- Severe intellectual disability, absent or minimal speech
- Infantile hypotonia → progressive spasticity (especially lower limbs)
- Recurrent severe respiratory infections: leading cause of mortality (~50% by age 25); thought to reflect intrinsic immune dysfunction plus aspiration
- Seizures in ~50% (often refractory; later-onset)
- Autistic features, stereotypies
- GI dysmotility, constipation
- Mild dysmorphic features: brachycephaly, midface hypoplasia, large ears (subtle, not pathognomonic)
- Genitourinary anomalies in some
- Chromosomal microarray (CMA) is the test; detects the Xq28 duplication. Karyotype usually misses it (too small).
- Increasingly identified prenatally on CMA performed for other indications; counsel carefully given variable size and uncertainty about minimal critical region.
- Confirm parental origin (maternal carrier vs de novo) for recurrence-risk counseling.
- Multidisciplinary developmental, neurology, pulmonology care
- Aggressive respiratory management: pneumonia surveillance, vaccination, prompt antibiotics; consider IVIG in selected cases of recurrent severe infections
- Seizure management
- Feeding/GI support
- Family planning: maternal carrier testing, prenatal diagnosis options, discuss preimplantation genetic testing
Same locus, opposite mechanisms, opposite sex predominance: MECP2 loss-of-function causes Rett (girls); MECP2 duplication / overexpression causes MECP2 duplication syndrome (boys).